Ravi Chopra

Ravi Chopra is a partner in the Private Investment Funds team and is a co-leader of Goodwin’s Secondaries practice. Ravi has a transatlantic practice focused on raising private capital vehicles, and conducting secondaries transactions, across private equity, healthcare and real assets.

Ravi also deals extensively with co-investment platforms and has particular expertise advising on preferred equity arrangements, GP-led transactions, longer-term capital and multicurrency solutions.

Representative matters include:

• Abingworth on its $465 million 13th life sciences fund, as well as on its $582 million dedicated clinical co- development fund and the sale of Abingworth to Carlyle in August 2022
• Ares Management on the structuring and establishment of its €1.78 billion European Real Estate Fund V and the establishment of several European co-investment vehicles
• BentallGreenOak on its €695 million European core-plus logistics real estate fund, as well as on its recent European real estate debt fundraisings
• Bregal Investments on various fundraising matters
• Capital Dynamics on its funds of funds, secondaries funds, direct co-investment funds, managed accounts, secondary transactions, and carry/co-investment arrangements
• ICG on a number of its European fundraisings, including its €8.1 billion eighth European Corporate fund
• LGT on the acquisition of the Indian impact investment platform Aspada from Soros Economic Development Fund (SEDF) as well as on fundraising and structuring matters across their various strategies
• Webster Equity Partners on over $5 billion of fundraising and transactions in the healthcare space
• Willis Towers Watson on fund investments and direct co-investments into European and US private equity, real estate, infrastructure, and credit

Ravi delivers regular seminars for Invest Europe and the Kauffman Fellows Program, introducing fund executives to fund structuring and related house economic considerations.

Ravi spent six months working in the UK Parliament from Q3 2009 to Q1 2010.

Ravi has achieved industry recognition as a rising star, including Financial News (2021) as a rising star in private equity, and Private Funds CFO (2023) as one of the 20 best up-and-coming private funds lawyers internationally. He is known for his innovative private market solutions, including use of preferred equity, secondaries and debt financing, as well as his focus on community work and mentoring.

Client testimonials in Legal 500 have noted his “outstanding technical skillset,” “sound commercial advice” and “solutions-oriented approach.”

Ravi is frequently quoted in respect of the European legal market, the impact of Brexit and secondaries markets. He has written extensively in relation to permanent capital vehicles and emerging markets, including contributing a chapter to Private Equity in Sub-Saharan Africa (PEI 2016), as well as an article for an EMPEA technical bulletin and an article for African Business Review.

Ravi's recent publications include:

• Co-Author, “Any Preference? Preferred Equity as Part of the Financing Toolkit,” Global Legal Insights Fund Finance, 2025
• Co-Author, “A preferred approach? Assessing preferred equity as part of the financing toolkit,” Global Legal Insights Fund Finance, 2024
• Quoted, “GP Workshop: How to Assess Whether to Exit to PE or Trade,” Real Deals, April 7, 2021
• Quoted, “Added Complexity For PE Firms as UK Funds Fall Outside of EU Regulation,” S&P Global Market Intelligence, March 1, 2021 
• Quoted, “Don’t Forget Brexit,” Private Equity International, December 3, 2020 
• Quoted, “Smooth Sailing,” Real Deals, November 26, 2020

Ravi's recent speaking engagements include:

• Panelist, “Planning the Future for UK Managers,” Goodwin Webinar, November 17, 2020